William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'

Go back to William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
Veramark Technologies, Inc. (NASDAQ: VERA) Delayed: 31.97 +1.26 (4.10%)
Previous Close $30.71    52 Week High $1.18 
Open $31.00    52 Week Low $0.36 
Day High $32.18    P/E 532.83 
Day Low $30.73    EPS $0.06 
Volume 1,877,281